How to Buy Day One Biopharmaceuticals Stock
Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers.
Day One Biopharmaceuticals stock last closed at $21.39, up 0.38% from the previous day, and has increased 158.33% in one year. It has overperformed other stocks in the Biotechnology industry by 2.03 percentage points. Day One Biopharmaceuticals stock is currently +279.59% from its 52-week low of $5.64, and -0.19% from its 52-week high of $21.43.
As of Mar 19, 2026, there are 103.3M shares of DAWN outstanding. The market value of DAWN is $2.21B. In the last 24 hours, 6.73M DAWN shares were traded.
How to Buy Day One Biopharmaceuticals Stock
Wondering how to invest in Day One Biopharmaceuticals stock? Here's how.
- Decide where to buy Day One Biopharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Day One Biopharmaceuticals stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit money your investment account: Select your payment method and add your details.
- Analyze Day One Biopharmaceuticals stock: The Day One Biopharmaceuticals ticker symbol is DAWN. Is Day One Biopharmaceuticals stock a good investment? Should you buy shares of DAWN? How do DAWN's underlying business fundamentals look? Do top analysts think Day One Biopharmaceuticals is a good buy? Why has DAWN's stock price moved recently? (Hint: Our stock market research tools can help you evaluate if DAWN is a good stock to buy).
- Place your DAWN trade: Decide if you will purchase DAWN shares at the current market price or use a limit order to purchase DAWN shares at a specific price.
- Monitor your investment in DAWN: Create a watchlist to important updates regarding your investment in Day One Biopharmaceuticals shares.
Step 1: Decide where to buy Day One Biopharmaceuticals stock
You need a brokerage account in order to access the NASDAQ market and buy DAWN stock.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to invest in DAWN today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new brokerage account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your investment account
Now that you've opened your account on the highest rated stock app, you can securely and quickly fund your account:
Watch the tutorial below to see the process of depositing money into your new brokerage account.
Step 4: Analyze Day One Biopharmaceuticals stock
After you have chosen the best place to buy Day One Biopharmaceuticals stock, it's important to research their stock before you invest, so you truly understand the risk as well as the upside.
Day One Biopharmaceuticals quick stats
Day One Biopharmaceuticals Fundamentals
WallStreetZen was created to help part-time investors perform more accurate fundamental analysis quickly.
You can see all of the due diligence checks on DAWN's stock page.
Is DAWN stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge DAWN's fair value.
Using relative valuations measures:
- DAWN may be overvalued based on its P/B ratio of 5.01x, relative to Biotechnology industry P/B ratio of 4.68x
You can do more valuation analysis on DAWN's stock here.
DAWN Financial Summary
Positive Financial Indicators:
- DAWN has cash burn of 104045000. It has sufficient cash and short-term investments to cover this for at least one year.
- DAWN has a low debt to equity ratio of 0.15.
- DAWN has $441.11M in cash and short term investments. This is sufficient to cover its annual cash burn of $104.05M.
- There are more short-term assets than short-term liabilities on the DAWN balance sheet.
- There are more short-term assets than long-term liabilities on the DAWN balance sheet.
- Total DAWN debt is lower than 5 years ago, relative to shareholder equity.
Negative Financial Indicators:
- DAWN profit margin has gone up by 0.05 percentage points in the past year, but the company is still unprofitable.
Do Wall Street analysts think it's a good time to buy Day One Biopharmaceuticals stock
Out of 7 Wall Street analysts who track DAWN, the consensus analyst rating on DAWN is a Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent DAWN Analyst Recommendations
Tara Bancroft, a top 33% analyst from TD Cowen initiates coverage on DAWN with a strong buy rating and announces their DAWN price target of $34.00, on Jan 13, 2026.
Kelsey Goodwin, a top 8% analyst from Piper Sandler maintains DAWN with a strong buy rating and raises their DAWN price target from $25.00 to $26.00, on Nov 5, 2025.
Piper Sandler's Kelsey Goodwin raised their price target on Day One Biopharmaceuticals (NASDAQ: DAWN) by 4% from $25 to $26 on 2025/11/05. The analyst maintained their Strong Buy rating on the stock.
Day One Biopharmaceuticals reported its Q3 2025 earnings.
Prior to the release of more long-term data, ongoing commercial performance, and ultimately 1L pLGG data in 2027, Goodwin argued that the stock's current valuation offers an appealing entry point into Day One Biopharmaceuticals.
Earnings Report
For Q3 2025, Day One Biopharmaceuticals reported:
- Loss per share of $0.19, which beat the Zacks Consensus Estimate of $(0.28) but missed, by 150%, Q3 2024’s $0.38.
- Revenue of $39.8M, which beat the Zacks Consensus Estimate by 5.75% but missed, by 57.6%, Q3 2024’s $93.76M.
Management did not provide EPS and revenue guidance in its press release.
CEO Jeremy Bender, Ph.D. commented: “Our Q3 results reflect acceleration across every key dimension of OJEMDA’s performance and growing confidence among prescribers as we continue to build the case for second-line standard-of-care through execution and additional data readouts.
“Combined with steady pipeline progress, we are well positioned to deliver sustainable growth for shareholders while we continue our mission to bring meaningful therapies to patients.”
You can dive deeper into what analysts are saying on the Day One Biopharmaceuticals stock forecast page.
DAWN Momentum
DAWN Earnings
Last year, DAWN revenue was $158.18M. Over the past 1 years, DAWN's revenue has grown by 20.6% per year. This was slower than the Biotechnology industry average of 29.02%.
Learn more about DAWN's earnings and revenue performance here.
What are DAWN insiders up to?
In the last year, executives and large shareholders at DAWN have sold more shares than they have bought.
Jeremy Bender, CHIEF EXECUTIVE OFFICER of DAWN, was the latest DAWN insider to sell. They sold $179,339.86 worth of DAWN stock on Feb 17, 2026.
Get more info about who owns DAWN stock here.
Can I get consistent income from DAWN stock?
No, Day One Biopharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about DAWN?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your DAWN trade
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given price limit, use a limit order.
Click the Open Trade button and eToro will execute your order.
If you want more help investing in stocks on eToro, click the helpful video below:
Step 6: Monitor your investment in DAWN
Now that you own some DAWN shares, you'll want to stay up-to-date on your new investment.
Start a watchlist to keep tabs on your DAWN stock.
DAWN Feed
How to Buy Stock in Day One Biopharmaceuticals
To summarize, here are the 6 steps to buy stock in Day One Biopharmaceuticals:
- Decide where to buy Day One Biopharmaceuticals stock
- Open your brokerage account
- Deposit money your investment account
- Analyze Day One Biopharmaceuticals stock
- Place your DAWN trade
- Monitor your investment in DAWN
If you require a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you want to monitor your investment in Day One Biopharmaceuticals, click below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.